Amphastar Pharmaceuticals Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Amphastar Pharmaceuticals Inc 's ROA in the third quarter of 2026?
Amphastar Pharmaceuticals Inc achieved a return on average assets (ROA) of 5.51 % in its third quarter of 2026, this is above AMPH's average return on assets of 4.84%.
Amphastar Pharmaceuticals Inc assets over the 12 months ending in its third quarter of 2026 are valued at $1,796 million

ROA has improved compared to 4.54% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 156 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from 1200 to 1220.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	15.97 %	22.01 %	1.18 %	3.18 %	7.83 %
Y / Y Net Income Change	117.65 %	-2.2 %	-74.61 %	-35.65 %	-57.09 %
Net Income (TTM) in million	99	79	79	98	112
Return On Assets (TTM)	5.51 %	4.54 %	4.83 %	6 %	6.88 %
AMPH's Total Ranking	# 1220	# 1200	# 899	# 747	# 692
Total Assets (TTM) in million	1,932	1,972	1,648	1,629	1,666
Seq. Total Assets Change	-2.03 %	19.67 %	1.16 %	-2.22 %	3.07 %
Seq. Net Income Change	24.43 %	372.71 %	-73.72 %	40.8 %	-44.09 %

AMPH's 5 Years Annual ROA >> Back to AMPH Management Effectiveness >> Compare AMPH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 57
Sector	# 157
Overall	# 1238

Return On Assets Statistics
High	Average	Low
13.36 %	4.84 %	-3.84 %
(Jun 30 2022)		(Jun 30 2015)

Financial Statements
Amphastar Pharmaceuticals Inc 's Assets	$ 1,932 million	AMPH's Balance sheet
Amphastar Pharmaceuticals Inc 's Income	$ 38 million	Quarterly AMPH's Income Statement
AMPH's Income by Division		See AMPH's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	3.18 %	4.28 %	104.01 %	10.54 %	6.38 %
Total Assets in million	1,629	1,579	1,514	742	672
Y / Y Net Income Change	-38.51 %	15.98 %	50.51 %	44.37 %	5670.37 %
Net Income in million	98	160	138	91	63
Annual Return On Assets	6.02 %	10.1 %	9.08 %	12.31 %	9.43 %

AMPH's 5 Years Annual ROA >> Back to AMPH Management Effectiveness >> Compare AMPH ROA to its Competitors

Comment on AMPH's ROA in the fiscal year ending 2025

In the fiscal year 2025 Amphastar Pharmaceuticals Inc 's ROA decreased compared to previous year to 6.02 %, due to deterioration of net income -38.51 % to $98.09 million, from $159.52 million a year ago, as AMPH's assets were $1,629.30 million.

More Return On Assets Ratios
AMPH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AMPH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AMPH's Competitors
Subscribers only: Roa for Amphastar Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for AMPH's Customers

You may also want to know
AMPH's Roi	AMPH's Inventory Turnover Ratio	AMPH's Growth Rates	AMPH's Dividend Comparisons
	AMPH's Profitability Ratios	AMPH's Asset Turnover Ratio	AMPH's Dividend Growth
AMPH's Roe	AMPH's Valuation Ratios	AMPH's Financial Strength Ratios	AMPH's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %
Tactile Systems Technology Inc	8.53 %
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Ani Pharmaceuticals Inc	7.77 %
Stryker Corp	7.66 %
Abbvie Inc	7.48 %
Ensign Group Inc	7.00 %

Date modified: 2026-11-06T12:56:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.